A Win For Nymox Pharmaceutical Corporation
Mon, Jul 03, 2023 at 06:45 PM
Nymox Pharmaceutical Corporation (NYMX:NASDAQ) soared at $0.26, a gain of 37.8%. From Tue, Jun 20, 2023, the stock recorded 22.22% Up Days and 30.00% Green Days
About Nymox Pharmaceutical Corporation (NYMX:NASDAQ)
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Top 10 Gainers:
- Fresh Vine Wine Inc. (VINE:NYSEMKT), 156.64%
- PolyMet Mining Corp. (PLM:NYSEMKT), 153.17%
- SRAX, Inc. (SRAX:NASDAQ), 85.71%
- SQZ Biotechnologies Company (SQZ:NYSE), 61.11%
- Canopy Growth Corporation (CGC:NASDAQ), 52.1%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 48.83%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 37.84%
- Yellow Corporation (YELL:NASDAQ), 37.55%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 28.96%
- Barnes & Noble Education, Inc. (BNED:NYSE), 28.57%